GB2494477A - A nutraceutical supplement - Google Patents

A nutraceutical supplement Download PDF

Info

Publication number
GB2494477A
GB2494477A GB1115778.1A GB201115778A GB2494477A GB 2494477 A GB2494477 A GB 2494477A GB 201115778 A GB201115778 A GB 201115778A GB 2494477 A GB2494477 A GB 2494477A
Authority
GB
United Kingdom
Prior art keywords
nutraceutical
active ingredient
text
supplement according
nutraceutical supplement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB1115778.1A
Other versions
GB201115778D0 (en
Inventor
Jules Birch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WORKS WITH WATER NUTRACEUTICALS Ltd
Original Assignee
WORKS WITH WATER NUTRACEUTICALS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WORKS WITH WATER NUTRACEUTICALS Ltd filed Critical WORKS WITH WATER NUTRACEUTICALS Ltd
Priority to GB1115778.1A priority Critical patent/GB2494477A/en
Publication of GB201115778D0 publication Critical patent/GB201115778D0/en
Publication of GB2494477A publication Critical patent/GB2494477A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A nutraceutical supplement in the form of a powder for administration to humans in a beverage or soft food. The nutraceutical powder preferably comprise fructooligosaccharides. The nutraceutical may also comprise and anti-oxidant, a skin rejuvenating active ingredient, a blood cholesterol lowering active ingredient, a blood pressure lowering active ingredient and additional ingredients such as sweetener, preservatives, colourings etc.

Description

Nutraceutical Supplement The present invention relates to a nutraceutical supplement, more specifically a nutraeeutical supplement in the form of a powder.
Nutraceuticals are foods or food products that provide health benefits.
Nutraceuticals are commonly provided in the form of dietary supplements (e.g. vitamin pills) and functional foods (e.g. iodine fortified salt and folic acid fortified flour). Nutraceuticals are becoming increasingly popular in Western society as individuals seek to improve their health and take care of themselves.
According to one aspect of the present invention, there is provided a nutraceutical supplement for administration to humans in the form of a powder for dissolution in a beverage or a soft food and for oral administration in the beverage or the soft food once per day. In the context of the present invention, the term "soft food" means a food with sufficient liquid content enabling dissolution of the nutraceutical supplement.
In use, a person need only add the nutraceuntical supplement to a beverage or soft food, e.g. orange juice or soup, stir to dissolve the nutraceuntical supplement in the beverage or the soft food, then consume the beverage or the soft food. Preferably, the nutraceutical supplements of the present invention have no discemable taste so that a person can enjoy a beverage or soft food containing the dissolved nutraceutical supplement as normal. This encourages a person to consume the nutraceutical supplement regularly.
In a preferred embodiment of the present invention, the nutraceutical supplement comprises fructooligosaccharides. Fructooligosaccharides aid in the dissolution of the active ingredients present in the nutraceutical supplement in the beverage or the soft food. In addition, fructooligosaccharides contribute dietary fibre to a person's diet. * 2
The inventors have found that a person taking the nutraccuntical supplement every day will see health benefits such as lowered blood pressure, lowered blood cholesterol or clearer skin in as little as six to eight weeks.
The nutraceutical supplements of the present invention can be provided in a box containing multiple individual sachets, each sachet containing a portion of the nutraceutical supplement The nutraceutical supplements of the present invention can be formulated to deliver particular, individual health benefits or to deliver combined health benefits.
For example, the nutraceuticaj supplements of the present invention may comprise skin rejuvenating active ingredients or the nutraceutical supplements of the present invention may comprise blood cholesterol lowering active ingredients or the nutraceutical supplements of the present invention may comprise b]ood pressure lowering active ingredients. Additionally, the nutraceutical supplements of the present invention can be formulated to be free from artificial colours and flavours, suitable for vegetarians, diabetics, eoeliacs and anyone on a calorie controlled diet.
In embodiments in which the nutraceutical supplements of the present invention comprise skin rejuvenating active ingredients, the nutraceutical supplements may comprise at least one anti-oxidant. The at least one anti-oxidant may be selected from the list consisting of CoEnzynieQlo, astaxanthin, zeaxanthin, lycopene, and combinations thereof CoEnzymeQlO is a proven anti-ageing agent that can be found in many topical anti-ageing creams as it has both energising and anti-oxidative properties (Shiseido Research Center, Coenzytne QJO protects against oxidative stress-induced cell death and enhances the synthesis of basement membrane components in dermal and epidertnal cells, Biofactors, Sept-Oct 2009, p. 435-41).
CoEnzymeQ 10 has also been proven be effective when taken as an oral supplement (De Luca C, Deeva I, Mikhai'Chik E, Korkina L, Beneficial effects of pro-antioxidant based nutraceuticals in the skin rejuvenation techniques, Cell Mol Biol (Noisy-le-grand), 15Ih April 2007, p. 94-101).
Nutraeeutical supplements comprising skin rejuvenating active ingredients may comprise other skin rejuvenating active ingredient in addition to or instead of the * 3 at least one anti-oxidant. The at least one skin rejuvenating active ingredient may be selected from the list consisting of aloe vera, dairy peptides, retinol, hydroxycitric acid, collagen, vitamin E, lycopene. beta carotene, tyrosine, biotin, and combinations thereof. Dairy peptides suitable for use as a skin rejuvenating active ingredient include whey protein rich in lactoferrin.
Aloe vera aids skin regeneration, whilst dairy protein concentrates rich in lactoferrin can help reduce the appearance of blemishes for a clearer, healthier complexion.
In embodiments in which the nutraceutical supplements of the present invention comprise blood cholesterol lowering active ingredients, the nutraceutical supplements may comprise at least one active ingredient selected from the list consisting of plant sterol esters, oat beta glucan, barley beta glucan and combinations thereof.
Plant sterol esters are plant compounds with a similar chemical structure to cholesterol. Plant sterol esters are known to reduce the absorption of cholesterol in the human body (Alvin Berger, Peter JR Jones and Suhad S Abumweis, Plant sterols: factors affecting their efficacy and safety as functional food ingredients, Lipids in Health and Disease, 2004) and have been scientifically proven to help lower cholesterol when consumed as part of a healthy diet. The European Food Safety Authority (EFSA) has approved plant sterol esters as one of the first food ingredients to have proven heart health benefits (European Food Safety Authority (EFSA), Scien4fic opinion on the substantiation of health claims related to plant sterols and plant stanols and maintenance of normal blood cholesterol concentrations, EPSA Journal 2010, p. 1813). Plant sterol esters are present in vegetable oils, nuts, seeds and grains, however, it may be difficult to consume a sufficient quantitiy to activate the cholesterol lowering effect (1.6 g).
In embodiments in which the nutraceutical supplements of the present invention comprise blood pressure lowering active ingredients, the nutraceutical supplements may comprise at least one active ingredient, such as dairy peptides.
Dairy peptides suitable for use as blood pressure lowering active ingredients include * 4 concentrated forms of isoleucine-proline-proline (IP?) oligopeptides, concentrated forms of valine-proline-proline (VPP) oligopeptides, and combinations thereof Elevated blood pressure can be caused by various factors, one of which is a constriction of blood vessels triggered by angiotensin 11. In the angiotensin converting reaction, called ACE', this hormone can cause blood vessels to constrict, or narrow, effectively raising blood pressure. Dairy peptides act as a natural blocker of this reaction, When the constriction is inhibited, elevation of blood pressure can be preventedand kept at a healthy level. Research by the British Journal of Nutrition has proven that dairy peptides are effective in the reduction of systolic and diastolic blood pressure. The study concluded that food or drink enriched with dairy peptides could assist in the prevention of hypertension in people with blood pressure that is above normal.
The nutraceutical supplements of the present invention may comprise further or alternative active ingredients selected from the list consisting of ascophyllu,n nodosurn, glucomannan, conjugated linoleic acid, zinc gluconate, magnesium gluconate, horsetail extract, docosahexaenoic acid and combinations thereof Whether the nutraceutical supplements of the present invention comprises at least one skin rejuvenating active ingredient, at least one anti-oxidant, at least one blood cholesterol lowering active ingredient, any other type of active ingredient, or a combination thereof, the amount of active ingredient present in the nutraceutical supplement will vary dependent on the specific active ingredient(s) used and the intended purpose of the specific active ingredient(s). The nutraceutical supplement of the present invention may comprise about 40 mg to about 80 mg of CoEnzymeQl 0, about 2 mg to about 6 mg of astaxanthin, about 2 mg to about 4 tug of zeaxanthin, about 8 mg to about 12 mg of lycopene, about 200 mg to about 300 mg of aloe vera, about 100mg to about 200mg of dairy peptides, about 0.5 pg to about 1.0 pg of retinol, about 0.3 g to about 0.6 g of hydroxycitric acid, about 2.5 g to about 3.5 g of collagen, about 5.0 mg to about 15.0 trig of vitamin E, about 8 tug to about 12 mg of lycopene, about 4.0 pg to about 6.0 pg of beta-carotene, about 0.4 g to about 0.6 g of tyrosine, about 50 pg to about 100 pg of biotin, about 0.25 g to about 0.75 g of ascophyllum nodosum, about 20 mg to about 30 mg of zinc gluconate, about 100 tug S 5 to about 300 mg of magnesium gluconate, about 150 mg to about 450 mg of horsetail extract, about 100 rig to about 200 mg of docosahexaenoic acid, about 1.0 g to about 2.0 g of glucomannan, about 1.0 g to about 1.5 g of conjugated linoleic acid, about 0.8 g to about 1.6 g of plant sterol esters, about 0.75 g to about 1.50 g of oat beta glucan, about 0.75 g to about 1.50 g barley beta glucan, or any combination thereof per portion of nutraceutical supplement.
The nutraceutical supplements of the present invention may comprise at least one sweetener. The at least one sweetener can be selected from the list consisting of sucralose, stevia (rebaudioside A), erythritol and combinations thereof.
The nutraceutical supplements of the present invention may comprise at least one preservative. The at least one preservative can be selected from the list consisting of potassium sorbate, citric acid, sorbic acid, sodium benzoate and combinations thereof The nutraceutical supplements of the present invention may comprise at least one flavouring. The at least one flavouring is preferably selected from natural fruit flavours, e.g. apple flavour.
The nutraceutieal supplements of the present invention may comprise at least one flavour enhancer. Citric acid is a flavour enhancer suitable for use with the present invention.

Claims (1)

  1. <claim-text>Claims: 1. A nutraceutical supplement for administration to humans in the form of a powder for delivery in a beverage or a soft food and for oral administration in the beverage or the soft food once per day.</claim-text> <claim-text>2. A nutraceutical supplement according to claim 1, comprising fructooligo-saccharides.</claim-text> <claim-text>3. A nutraceutical supplement according to claim 1, comprising at least one anti-oxidant.</claim-text> <claim-text>4. A mitraceutical supplement according to claim 3, wherein the at least one anti-oxidant is selected from the list consisting of CoEnzyineQlO, astaxanthin, zeaxanthin, lycopene, and combinations thereof 5. A nutraccutical supplement according to any preceding claim comprising at least one skin rejuvenating active ingredient.6. A nutraceutical supplement according to claim 5, wherein the at least one skin rejuvenating active ingredient is selected from the list consisting of aloe vera, dairy peptides such as whey protein rich in lactoferrin, retinol, hydroxycitric acid, collagen, vitamin E, lycopene, beta carotene, tyrosine, and combinations thereof.7. A nutraceutical supplement according to any preceding claim comprising at least one blood cholesterol lowering active ingredient.8. A nutraceutical supplement according to claim 7, wherein the at least one blood cholesterol lowering active ingredient is selected from the list consisting of plant sterol esters, oat beta glucan, barley beta glucan and combinations thereof 9. A nutraceutical supplement according to any preceding claim comprising at least one blood pressure lowering active ingredient. S 710. A nutraceutical supplement according to claim 9, wherein the at least one blood pressure lowering active ingredient comprises dairy peptides such as concentrated forms of isoleucine-proline-proline (IPP) oligopeptides, concentrated forms of valine-proline-proline (VPP) oligopeptides, and combinations thereof.11. A nutraceutical supplement according to any preceding claim further comprising one or more additional ingredients selected from the list consisting of sweeteners, preservatives, flavourings, flavour enhancers, colourings and combinations thereof.12. A nutraceutical supplement substantially as described herein.</claim-text>
GB1115778.1A 2011-09-12 2011-09-12 A nutraceutical supplement Withdrawn GB2494477A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1115778.1A GB2494477A (en) 2011-09-12 2011-09-12 A nutraceutical supplement

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1115778.1A GB2494477A (en) 2011-09-12 2011-09-12 A nutraceutical supplement

Publications (2)

Publication Number Publication Date
GB201115778D0 GB201115778D0 (en) 2011-10-26
GB2494477A true GB2494477A (en) 2013-03-13

Family

ID=44908466

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1115778.1A Withdrawn GB2494477A (en) 2011-09-12 2011-09-12 A nutraceutical supplement

Country Status (1)

Country Link
GB (1) GB2494477A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040156923A1 (en) * 2002-10-23 2004-08-12 Davenport David F. Method and nutraceutical composition for mammals
US6855358B1 (en) * 2002-11-01 2005-02-15 Enhanced Beverages, Llc Process for addition of a nutraceutical to a beverage
EP2036445A1 (en) * 2007-09-05 2009-03-18 Dietetics Pharma S.r.l. Nutraceutic preparation in powder form containing free plant sterols
WO2010137939A1 (en) * 2009-05-25 2010-12-02 Woon San Liang Method for producing a nutraceutical composition and the nutraceutical produced by the method
WO2011161501A2 (en) * 2010-06-21 2011-12-29 Labomar S.R.L. Solid compositions in form of powders or granulates for the oral administration of active ingredients and method for obtaining them

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040156923A1 (en) * 2002-10-23 2004-08-12 Davenport David F. Method and nutraceutical composition for mammals
US6855358B1 (en) * 2002-11-01 2005-02-15 Enhanced Beverages, Llc Process for addition of a nutraceutical to a beverage
EP2036445A1 (en) * 2007-09-05 2009-03-18 Dietetics Pharma S.r.l. Nutraceutic preparation in powder form containing free plant sterols
WO2010137939A1 (en) * 2009-05-25 2010-12-02 Woon San Liang Method for producing a nutraceutical composition and the nutraceutical produced by the method
WO2011161501A2 (en) * 2010-06-21 2011-12-29 Labomar S.R.L. Solid compositions in form of powders or granulates for the oral administration of active ingredients and method for obtaining them

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
http://www.nellsonllc.com/dry-blending-agglomeration.html *

Also Published As

Publication number Publication date
GB201115778D0 (en) 2011-10-26

Similar Documents

Publication Publication Date Title
US7780873B2 (en) Bioactive complexes compositions and methods of use thereof
EP2203070B1 (en) Pomegranate extracts, nutritional products containing them and their uses
US9393190B2 (en) Methods for enhancing skin tan and reducing risks of UV skin damage
CA2996627A1 (en) Compositions and methods for acutely raising nitic oxide levels
WO2004066988A1 (en) Fatigue reducing agent
US20090202679A1 (en) Composition comprising fish oil and juices
AU2011213557B2 (en) Carrier comprising non-neutralised tocopheryl phosphate
US20140045874A1 (en) Prevention of alcohol reaction with dietary supplements
WO2014173418A1 (en) Compositions for use in restoring muscle glycogen and/or muscle mass
US20150173410A1 (en) Beverage comprising omega fatty acid
JP2011500078A (en) Functional beverage
JP2010030901A (en) Agent for alleviating or preventing stress symptom
ES2691199T3 (en) Oral composition to strengthen skin tolerance after topical administration of a retinoid compound
WO2019240839A2 (en) Compositions for enhanced recovery after surgery (eras)
Taeymans et al. 55 use of food supplements as nutricosmetics in health and fitness
CN115279209A (en) Coenzyme Q production promoter and coenzyme Q production promoting method
GB2494475A (en) A nutraceutical supplement and method of making
JP4818637B2 (en) Low density lipoprotein (LDL) oxidation inhibitor
WO2012116992A2 (en) Oral use
TWI566772B (en) Whitening agent and malanin production inhibitor
GB2494477A (en) A nutraceutical supplement
CN101861990B (en) Pearl vitamin C buccal tablets
ES2217966B1 (en) FOOD PRODUCTS THAT INCLUDE AN EXTRACT OF HOLLEJO, SEEDS AND GRAPE SCRATCHES.
JP4672304B2 (en) Lipolysis accelerator
Downs et al. PerformLyte—A Prodosomed PL425 PEC Phytoceutical-Enriched Electrolyte Supplement—Supports Nutrient Repletion, Healthy Blood pH, Neuromuscular Synergy, Cellular and Metabolic Homeostasis

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)